All companies › TNYA

TNYA · Tenaya Therapeutics, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
7
Open-market sells
0
INSIDER SCANNER signals
2026-08-17
Last filing

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

SEC Form 4 filings

Every open-market transaction disclosed for TNYA in the synced window. Values are the insider's own, as filed.

DateInsiderTitleTypeSharesPriceValue
2026-08-17 Ali Faraz Chief Executive Officer Open-market sell 5,837 0.71 $4,143
2026-08-17 Ali Faraz Chief Executive Officer Open-market sell 3,969 0.71 $2,817
2026-08-17 Ali Faraz Chief Executive Officer Open-market sell 5,020 0.71 $3,563
2026-08-17 Ali Faraz Chief Executive Officer Open-market sell 7,406 0.71 $5,256
2026-08-17 Tingley Whittemore Chief Medical Officer Open-market sell 1,637 0.71 $1,162
2026-08-17 Tingley Whittemore Chief Medical Officer Open-market sell 1,871 0.71 $1,328
2026-08-17 Tingley Whittemore Chief Medical Officer Open-market sell 2,279 0.71 $1,618

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.